Mesenchymal Stem Cells Prevent Acute Rejection and Prolong Graft Function in Pancreatic Islet Transplantation

MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2

(2009) G. M. Spaggiari et al.   BLOOD

Mesenchymal Stem Cells Prevent the Rejection of Fully Allogenic Islet Grafts by the Immunosuppressive Activity of Matrix Metalloproteinase-2 and -9

(2009) Y. Ding et al.   DIABETES

Islet Cell Transplantation in Diabetes Mellitus — from Bench to Bedside

(2009) Reinhard Bretzel et al.   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

Soluble mediators from mesenchymal stem cells suppress T cell proliferation by inducing IL-10

(2009) Seung-Ha Yang et al.   EXPERIMENTAL AND MOLECULAR MEDICINE

Species Variation in the Mechanisms of Mesenchymal Stem Cell-Mediated Immunosuppression

(2009) Guangwen Ren et al.   STEM CELLS

Bone Marrow–Derived Mesenchymal Stem Cells Improve Islet Graft Function in Diabetic Rats

(2009) M. Figliuzzi et al.   TRANSPLANTATION PROCEEDINGS

Use of donor bone marrow mesenchymal stem cells for treatment of skin allograft rejection in a preclinical rat model

(2008) Paolo Sbano et al.   ARCHIVES OF DERMATOLOGICAL RESEARCH

Optimal implantation site for pancreatic islet transplantation

(2008) S. Merani et al.   BRITISH JOURNAL OF SURGERY

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

(2008) Katarina Le Blanc et al.   LANCET

Cellular Islet Autoimmunity Associates with Clinical Outcome of Islet Cell Transplantation

(2008) Volkert A. L. Huurman et al.   PLoS One

Transplantation: current developments and future directions; The future of clinical islet transplantation as a cure for diabetes

(2007) Anthony Hogan   Frontiers in Bioscience-Landmark